Log In
BCIQ
Print this Print this
 

Angiotensin II type 1 (AT1) receptor (AGTR1)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Angiotensin II type 1 (AT1) receptor (AGTR1)

BCIQ
Print ChartPrint this
0 0 0 0 1 0 0 1 0 2 0 0 2 0 1 1 1 3 2 21
Phases of DevelopmentPreclinicalPhase IIPhase IIIApprovedMarketed
Cardiovascular

1

1

3

2

21

Endocrine / Metabolic

0

0

2

0

1

Neurology

0

0

1

0

2

Renal

0

0

0

0

1




 Products Targeting Angiotensin II type 1 (AT1) receptor (AGTR1)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

6

0

0

$430.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today